HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4(+) T Cells

Ítems similars

• A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5
  per: Tilton, John C., et al.
  Publicat: (2010)
• HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism
  per: Roche, Michael, et al.
  Publicat: (2011)
• Short-term variation of HIV tropism readouts in the absence of CCR5 antagonists
  per: Brumme, CJ, et al.
  Publicat: (2010)
• An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 Envelopes
  per: Sterjovski, Jasminka, et al.
  Publicat: (2010)
• Analysis of Binding Sites for the New Small-Molecule CCR5 Antagonist TAK-220 on Human CCR5
  per: Nishikawa, Masao, et al.
  Publicat: (2005)